Journal of Hepatology
Elsevier BV · DK · ISSN 01688278
SJR Q1
What the numbers say
More papers are appearing while average citedness has eased.
Field-weighted citation impact moved from 1.54 to 1.29. Expect a paper here to attract fewer citations on average than before. Annual output went from 2,231 to 2,419 papers. If speedy publication volume matters, this venue is publishing more frequently. Liver Disease and Transplantation rose from 9.8% to 14.6% of what the journal runs. Consider submitting clinical transplantation work given its larger presence. Recent titles increasingly carry thu- · wed- · sat- · fri- · masld. Check keyword trends if you want your title to match recent thematic language.
Citation metrics
SJR quartile
Q1
SJR score
13.10
Citations / doc (2y)
16.62
h-index
380
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
PapersField-weighted impact
2018
2,231
1.54
2019
2,195
1.24
2020
2,293
1.56
2021
601
5.60
2022
2,263
1.34
2023
2,467
1.87
2024
2,476
1.47
2025
2,419
1.29
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
Rising
- Liver Disease and Transplantation9.8%→14.6%+4.9%pPrevNow
- Hepatocellular Carcinoma Treatment and Prognosis3.8%→5.9%+2.1%pPrevNow
Falling
- Liver Disease Diagnosis and Treatment41.6%→30.2%−11.4%pPrevNow
- Hepatitis C virus research8.7%→6.3%−2.3%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
thu-wed-sat-fri-masldeurotips
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- US22.9%→22.9%+0.0%pPrevNow
- CN15.2%→19.4%+4.3%pPrevNow
- GB13.8%→12.9%−0.8%pPrevNow
- DE10.9%→12.3%+1.5%pPrevNow
- FR10.2%→9.2%−1.0%pPrevNow
- ES9.5%→9.2%−0.3%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
- Inserm439
Recently published
20The 20 most recent papers — not the full list.
1
Article2026
Contents2
Article2026
Applications for the EASL Schools 2027 open on 29 July. Discover them!Linguistics and LanguageSocial Sciences
3
4
Article2026
Submit your application for the Mobility / Research Fellowship Programme now!Physical Therapy, Sports Therapy and RehabilitationHealth Professions
5
6
Article2026
Become an EASL member today! Enjoy reduced fees at EASL events, apply to fellowships opportunities, attend an EASL School, and more!Information SystemsComputer Science
7
Article2026
From the Editor’s Desk…P Newsome*, F Tacke, Heiner Wedemeyer, Lorenza Rimassa, Annalisa Berzigotti, Tom H. Karlsen, Vlad Ratziu
EpidemiologyMedicine
8
Article2026
Response to Muhammad Uwais Ashra, et alClaudia Campani, Jean‐Charles Nault*
Public Health, Environmental and Occupational HealthMedicine
9
Article2026
Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapyYen‐Chun Liu, Yun‐Fan Liaw
EpidemiologyMedicine
10
Article2026
Sustainable hepatology beyond carbonEivind Engebretsen*
Health, Toxicology and MutagenesisEnvironmental Science
11
Article2026
Hepatic-IL-22RA1 is indispensable for IL-22-induced in vitro expansion of primary mouse hepatocytesXiaonan Ma, Xin Wang, Haili Tian, Yuxuan Huang, Shangyu Hong*
HepatologyMedicine
12
Article2026
The Ghost in the Diagnostic Machine: Purging Incomplete Septal Fibrosis from the Definition of PSVDDhiraj Agrawal*, Sudha Kodali
Pulmonary and Respiratory MedicineMedicine
13
Article2026
When Lipids Silence Immunity: Dendritic Cell Death in MASLD-associated HCCLorenz Kocheise, Kai Markus Schneider*
ImmunologyImmunology and Microbiology
14
Article2026
Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβPeng Xiao, Qiuhong Zai, Ningning Ma, Junhua Zhang, Yawen Hao, Yi Zhou, Feiyu Zhang, Tao Liu, Heming Sun, Junhua Zhang, Xinyi Liu, Shujun Ge, Shijia Ling, Yuehua Chen, Yixin Li, Liu Yang, Gang Ren, Robim M. Rodrigues, Xiaogang Xiang, M Li, Niu Jq, Yanhang Gao*, Yong He*
PharmacologyPharmacology, Toxicology and Pharmaceutics
15
Article2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma.Pasquale Lombardi, Erik Ramon‐Gil, Rabial Q. Raja, Leonardo Brunetti, Giulia Francesca Manfredi, Zhongguo Zhou, George Merces, Sarah Cappuyns, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Aria Torkpour, Ciro Celsa, Bernardo Stefanini, H. J. Yang, Fionnuala Crowley, Thomas U. Marron, Anwaar Saeed, Matthias Pinter, B Scheiner, Yi‐Hsiang Huang, Pei‐Chang Lee, Naoshi Nishida, Po‐Ting Lin, Andrea Dalbeni, Caterina Vivaldi, Gianluca Masi, Natascha Rohlen, Johann von Felden, Ahmed Kaseb, Peter R. Galle, Masatoshi Kudo, Wei‐Fan Hsu, Lorenza Rimassa, Alessandro Parisi, Robin Kate Kelley, Hidenori Toyoda, Mario Pirisi, Falah Jabar, Mehrdad Rakaee, Giuseppe Cabibbo, Calogero Cammà, Fabio Piscaglia, Sohyun Hwang, Dong Jun Shin, Michael Li, Jeroen Dekervel, Nadia Guerra, Tim Meyer, Helen L. Reeves, Bertram Bengsch, Gennaro Daniele, Derek A. Mann, Hong Jae Chon*, Jack Leslie*, David J. Pinato*
OAHepatologyMedicine
16
Article2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, Hannah Kalvin, Omar Zaki, Louise Connell, J.R. Harding, Eileen M. O’Reilly, Ghassan K. Abou‐Alfa, Neeta Vachharajani, Majella Doyle, B Tan, Adeel Khan, Ryan Fields, Stijn Franssen, Wills Filipe, Florian Buisman, Bianca Mostert, Marjolein Homs, Michail Doukas, Britte ten Haaft, Rutger-Jan Swijnenburg, Heinz‐Josef Klümpen, Jeroen Hagendoorn, Nadia Haj Mohammad, F. D‘Amico, Kevin C. Soares, T. Peter Kingham, Wei Alice, Michael D'Angelica, Mithat Gönen, W Chapman, Kemeny Ne, Andrea Cercek, William R. Jarnagin*, Bas Groot Koerkamp
SurgeryMedicine
17
Article2026
Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver diseaseChengji Dong, Xiaowei Zhong, Qi Peng, Zoe Müller, Julia Beimdiek, Katrin Splith, Linda Feldbrügge, Tobias Cantz, Manvendra K. Singh, Falk F. R. Buettner, Heike Bantel, H Wedemeyer, Michael Ott, Asha Balakrishnan, Amar Deep Sharma*
Molecular BiologyBiochemistry, Genetics and Molecular Biology
18
Article2026
Reply to: “Ketogenic diets in MASLD: methodological limitations and the confounding role of protein intake”Sami F. Qadri, Hannele Yki-Järvinen, Panu K. Luukkonen*
OAPhysiologyMedicine
19
Article2026
Reply to: “Agree to disagree; increasing the impact of recommendations formulated through Delphi methodology”María Pilar Ballester, Christopher F. Rose, Rajiv Jalan
Sociology and Political ScienceSocial Sciences
20
Article2026
Before repurposing Fusobacterium nucleatum in alcohol-associated liver disease: it is a rare, non-resident organism in the human alcoholic gutChetan Kalal*, Piyush Gupta
Infectious DiseasesMedicine
Most cited
20Top 20 most cited, 2018 – 2026.
1
ReviewCitations 11,4852018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaPeter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean‐Luc Raoul, Peter Schirmacher, Valérie Vilgrain
OAHepatologyMedicine
2
ReviewCitations 4,4102020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam*, Philip N. Newsome*, Shiv Kumar Sarin, Quentin M. Anstee, Giovanni Targher, Manuel Romero‐Gómez, Shira Zelber‐Sagi, Vincent Wai‐Sun Wong, Jean‐François Dufour, Jörn M. Schattenberg, Takumi Kawaguchi, Marco Arrese, Luca Valenti, Gamal Shiha, Claudio Tiribelli, Hannele Yki‐Järvinen, Jian-Gao Fan, Henning Grønbæk, Yusuf Yılmaz, Helena Cortez‐Pinto, Cláudia P. Oliveira, Pierre Bédossa, Leon A. Adams, Ming‐Hua Zheng, Yasser Fouad, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Sang Hoon Ahn, Laurent Castéra, Elisabetta Bugianesi, Vlad Ratziu*, Jacob George*
OAEpidemiologyMedicine
3
ReviewCitations 4,1512021
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateMaría Reig, Alejandro Forner, Jordi Rimola, Joana Ferrer, Marta Burrel, Ángeles García‐Criado, Robin Kate Kelley, Peter R. Galle, Vincenzo Mazzaferro, Riad Salem, Bruno Sangro, Amit G. Singal, Arndt Vogel, Josep Fuster, Carmen Ayuso, Jordi Bruix
OAHepatologyMedicine
4
ReviewCitations 3,7292018
Burden of liver diseases in the worldSumeet K. Asrani, Harshad Devarbhavi, John E. Eaton, Patrick S. Kamath
EpidemiologyMedicine
5
ArticleCitations 2,8482018
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisPaolo Angeli, Mauro Bernardi, Càndid Villanueva, Claire Francoz, Rajeshwar P. Mookerjee, Jonel Trebicka, Aleksander Krag, Wim Laleman, Pere Ginès
OAHepatologyMedicine
6
ArticleCitations 2,8392018
EASL Recommendations on Treatment of Hepatitis C 2018Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo, Marina Berenguer, Olav Dalgård, Geoffrey Dusheiko, Fiona Marra, Massimo Puoti, Heiner Wedemeyer
HepatologyMedicine
7
ReviewCitations 2,6982023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella*, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome*
OAEpidemiologyMedicine
8
ReviewCitations 2,6692021
Baveno VII – Renewing consensus in portal hypertensionRoberto de Franchis, Jaime Bosch, Guadalupe García–Tsao, Thomas Reiberger, Cristina Ripoll, Juan G. Abraldeṣ, Agustı́n Albillos, Anna Baiges, Jasmohan S. Bajaj, Rafael Bañares, Marta Barrufet, Lina Benajiba, Annalisa Berzigotti, Christophe Bureau, Vincenza Calvaruso, Andrés Cárdenas, Gennaro D’Amico, Andrea De Gottardi, Alessandra Dell’Era, Àngels Escorsell, Jonathan Fallowfield, Héctor Ferral, Sven Francque, Ron C. Gaba, Juan Carlos García‐Pagán, Joan Genescà, Susana Rodrigues, Jordi Gracia‐Sancho, Guogong Han, Virginia Hernández–Gea, Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji
OAHepatologyMedicine
9
ReviewCitations 2,2082019
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysisZobair M. Younossi*, Pegah Golabi, Leyla de Avila, James M. Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader
EpidemiologyMedicine
10
ReviewCitations 2,1752018
Non-alcoholic fatty liver disease – A global public health perspectiveZobair M. Younossi*
OAEpidemiologyMedicine
11
ArticleCitations 2,0522022
Global burden of primary liver cancer in 2020 and predictions to 2040Harriet Rumgay*, Melina Arnold, Jacques Ferlay, Olufunmilayo Lesi, Citadel J. Cabasag, Jérôme Vignat, Mathieu Laversanne, Katherine A. McGlynn, Isabelle Soerjomataram
OAHepatologyMedicine
12
ReviewCitations 2,0432019
The gut-liver axis in liver disease: Pathophysiological basis for therapyAgustı́n Albillos, Andrea De Gottardi, María Rescigno
OAMolecular BiologyBiochemistry, Genetics and Molecular Biology
13
ArticleCitations 2,0082018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi*
OAEpidemiologyMedicine
14
ReviewCitations 1,9962023
Global burden of liver disease: 2023 updateHarshad Devarbhavi, Sumeet K. Asrani*, Juan Pablo Arab, Yvonne Ayerki Nartey, Elisa Pose, Patrick S. Kamath
OAEpidemiologyMedicine
15
ArticleCitations 1,7532021
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateAnnalisa Berzigotti, Emmanouil Tsochatzis, Jérôme Boursier, Laurent Castéra, Nora Cazzagon, Mireen Friedrich‐Rust, Salvatore Petta, Maja Thiele
OAEpidemiologyMedicine
16
ArticleCitations 1,6502024
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber‐Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki‐Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker
OAEpidemiologyMedicine
17
ArticleCitations 1,6312021
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinomaAnn‐Lii Cheng*, Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae‐You Kim, Ho Yeong Lim, Masatoshi Kudo, В. В. Бредер, Philippe Merle, Ahmed O. Kaseb, Daneng Li, Wendy Verret, Ning Ma, Alan Nicholas, Yifan Wang, Lindong Li, Andrew X. Zhu, Richard S. Finn*
OAHepatologyMedicine
18
ArticleCitations 1,2262020
EASL recommendations on treatment of hepatitis C: Final update of the series☆Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo, Marina Berenguer, Olav Dalgård, Geoffrey Dusheiko, Fiona Marra, Massimo Puoti, Heiner Wedemeyer
HepatologyMedicine
19
ArticleCitations 1,1302019
EASL Clinical Practice Guidelines: Drug-induced liver injuryRaúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak‐Ublick, Dominique Larrey, Tom H. Karlsen
PharmacologyPharmacology, Toxicology and Pharmaceutics
20
ReviewCitations 1,1102020
Epidemiology and surveillance for hepatocellular carcinoma: New trendsAmit G. Singal, Pietro Lampertico, Pierre Nahon
OAHepatologyMedicine
Similar journals
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05